TransMedics Operating Income from 2010 to 2025

TMDX Stock

USD 67.67 3.29 4.64%

TransMedics Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit TransMedics Group generates from its operations. View All Fundamentals

Operating Income

First Reported

2018-03-31

Previous Quarter

3.9 M

Current Value

8.6 M

Quarterly Volatility

8 M

Covid

Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 15.1 M, Selling General Administrative of 177 M or Operating Income of 39.4 M, as well as many indicators such as Price To Sales Ratio of 4.46, Dividend Yield of 0.0 or PTB Ratio of 9.52. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.

Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Operating Income Growth Pattern

Below is the plot of the Operating Income of TransMedics Group over the last few years. Operating Income is the amount of profit realized from TransMedics Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of TransMedics Group is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. TransMedics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

TransMedics Operating Income Regression Statistics

	Arithmetic Mean	(17,220,950)
	Geometric Mean	26,075,047
	Coefficient Of Variation	(129.68)
	Mean Deviation	13,913,588
	Median	(22,986,000)
	Standard Deviation	22,332,810
	Sample Variance	498.8T
	Range	78.8M
	R-Value	0.43
	Mean Square Error	437.3T
	R-Squared	0.18
	Significance	0.1
	Slope	1,999,312
	Total Sum of Squares	7481.3T

TransMedics Operating Income History

	2025	39.4 M
	2024	37.5 M
	2023	-28.7 M
	2022	-31.4 M
	2021	-39.4 M
	2020	-26.4 M
	2019	-29.6 M

Other Fundumenentals of TransMedics Group

Non Operating Income Net Other

TransMedics Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Intangible Assets
Total Assets		0.8	0.82	-0.72	0.7	0.99	-0.45	0.96	0.99	0.68	0.91	0.99	0.97	0.74	0.61	0.8	0.97	-0.78	0.99	-0.12	-0.65	0.84	-0.74
Total Stockholder Equity	0.8		0.95	-0.77	0.48	0.73	-0.21	0.69	0.83	0.94	0.89	0.79	0.67	0.39	0.92	0.61	0.91	-0.59	0.86	0.36	-0.9	0.93	-0.56
Net Tangible Assets	0.82	0.95		-0.75	0.5	0.75	-0.14	0.71	0.86	0.89	0.9	0.79	0.69	0.38	0.81	0.57	0.89	-0.55	0.88	0.2	-0.93	0.96	-0.53
Retained Earnings	-0.72	-0.77	-0.75		-0.64	-0.65	0.06	-0.65	-0.77	-0.83	-0.81	-0.66	-0.61	-0.33	-0.79	-0.44	-0.79	0.44	-0.76	-0.28	0.79	-0.83	0.42
Accounts Payable	0.7	0.48	0.5	-0.64		0.75	-0.3	0.73	0.71	0.56	0.62	0.64	0.75	0.66	0.51	0.45	0.69	-0.28	0.69	0.0	-0.52	0.58	-0.24
Long Term Debt	0.99	0.73	0.75	-0.65	0.75		-0.48	0.98	0.97	0.62	0.85	0.97	0.99	0.82	0.56	0.78	0.94	-0.76	0.96	-0.14	-0.57	0.77	-0.72
Short Term Investments	-0.45	-0.21	-0.14	0.06	-0.3	-0.48		-0.52	-0.41	-0.1	-0.44	-0.5	-0.5	-0.24	-0.05	-0.38	-0.37	0.36	-0.42	0.5	-0.11	-0.25	0.35
Total Liab	0.96	0.69	0.71	-0.65	0.73	0.98	-0.52		0.94	0.58	0.84	0.95	0.97	0.8	0.52	0.76	0.92	-0.74	0.94	-0.17	-0.54	0.74	-0.71
Total Current Assets	0.99	0.83	0.86	-0.77	0.71	0.97	-0.41	0.94		0.74	0.93	0.96	0.95	0.68	0.66	0.73	0.98	-0.71	1.0	-0.09	-0.7	0.89	-0.68
Common Stock	0.68	0.94	0.89	-0.83	0.56	0.62	-0.1	0.58	0.74		0.82	0.64	0.56	0.27	0.97	0.44	0.82	-0.32	0.76	0.48	-0.94	0.92	-0.28
Property Plant Equipment	0.91	0.89	0.9	-0.81	0.62	0.85	-0.44	0.84	0.93	0.82		0.9	0.81	0.44	0.73	0.68	0.94	-0.66	0.94	0.0	-0.77	0.95	-0.63
Net Receivables	0.99	0.79	0.79	-0.66	0.64	0.97	-0.5	0.95	0.96	0.64	0.9		0.94	0.73	0.58	0.87	0.95	-0.85	0.96	-0.14	-0.59	0.81	-0.81
Current Deferred Revenue	0.97	0.67	0.69	-0.61	0.75	0.99	-0.5	0.97	0.95	0.56	0.81	0.94		0.85	0.5	0.73	0.91	-0.71	0.94	-0.19	-0.5	0.72	-0.68
Net Debt	0.74	0.39	0.38	-0.33	0.66	0.82	-0.24	0.8	0.68	0.27	0.44	0.73	0.85		0.3	0.66	0.67	-0.64	0.66	-0.06	-0.26	0.34	-0.61
Long Term Debt Total	0.61	0.92	0.81	-0.79	0.51	0.56	-0.05	0.52	0.66	0.97	0.73	0.58	0.5	0.3		0.43	0.78	-0.34	0.68	0.64	-0.89	0.82	-0.31
Capital Surpluse	0.8	0.61	0.57	-0.44	0.45	0.78	-0.38	0.76	0.73	0.44	0.68	0.87	0.73	0.66	0.43		0.75	-0.85	0.72	-0.11	-0.42	0.6	-0.78
Net Invested Capital	0.97	0.91	0.89	-0.79	0.69	0.94	-0.37	0.92	0.98	0.82	0.94	0.95	0.91	0.67	0.78	0.75		-0.73	0.98	0.1	-0.77	0.9	-0.69
Short Long Term Debt	-0.78	-0.59	-0.55	0.44	-0.28	-0.76	0.36	-0.74	-0.71	-0.32	-0.66	-0.85	-0.71	-0.64	-0.34	-0.85	-0.73		-0.7	0.11	0.33	-0.49	0.99
Net Working Capital	0.99	0.86	0.88	-0.76	0.69	0.96	-0.42	0.94	1.0	0.76	0.94	0.96	0.94	0.66	0.68	0.72	0.98	-0.7		-0.06	-0.73	0.9	-0.67
Short Term Debt	-0.12	0.36	0.2	-0.28	0.0	-0.14	0.5	-0.17	-0.09	0.48	0.0	-0.14	-0.19	-0.06	0.64	-0.11	0.1	0.11	-0.06		-0.47	0.13	0.1
Deferred Long Term Liab	-0.65	-0.9	-0.93	0.79	-0.52	-0.57	-0.11	-0.54	-0.7	-0.94	-0.77	-0.59	-0.5	-0.26	-0.89	-0.42	-0.77	0.33	-0.73	-0.47		-0.89	0.3
Capital Stock	0.84	0.93	0.96	-0.83	0.58	0.77	-0.25	0.74	0.89	0.92	0.95	0.81	0.72	0.34	0.82	0.6	0.9	-0.49	0.9	0.13	-0.89		-0.45
Intangible Assets	-0.74	-0.56	-0.53	0.42	-0.24	-0.72	0.35	-0.71	-0.68	-0.28	-0.63	-0.81	-0.68	-0.61	-0.31	-0.78	-0.69	0.99	-0.67	0.1	0.3	-0.45

Click cells to compare fundamentals

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	37.5 M	39.4 M
Non Operating Income Net Other	-789.3 K	-828.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TransMedics Operating Income from 2010 to 2025

Latest TransMedics' Operating Income Growth Pattern

TransMedics Operating Income Regression Statistics

TransMedics Operating Income History

Other Fundumenentals of TransMedics Group

TransMedics Operating Income component correlations

About TransMedics Financial Statements

Also Currently Popular

Additional Tools for TransMedics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY